These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26748487)

  • 21. Poor effectiveness of proton pump inhibitors in non-erosive reflux disease: the truth in the end!
    Scarpignato C
    Neurogastroenterol Motil; 2012 Aug; 24(8):697-704. PubMed ID: 22783985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-erosive reflux disease (NERD), symptomatic and asymptomatic erosive reflux disease (ERD): from hypersensitive to hyposensitive esophagus.
    Hartono JL; Qua CS; Goh KL
    Dig Dis Sci; 2011 Jan; 56(1):90-6. PubMed ID: 20467897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histology of symptomatic gastroesophageal reflux disease: is it predictive of response to proton pump inhibitors?
    Miwa H; Takubo K; Shimatani T; Furuta T; Oshima T; Tanaka J; Aida J; Ito M; Kurosawa S; Joh T; Wada T; Habu Y; Watanabe Y; Hongo M; Chiba T; Kinoshita Y;
    J Gastroenterol Hepatol; 2013 Mar; 28(3):479-87. PubMed ID: 22989221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart rate variability in patients with different manifestations of gastroesophageal reflux disease.
    Lee YC; Wang HP; Lin LY; Lee BC; Chiu HM; Wu MS; Chen MF; Lin JT
    Auton Neurosci; 2004 Nov; 116(1-2):39-45. PubMed ID: 15556836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with residual gastroesophageal reflux disease symptoms in patients receiving proton pump inhibitor maintenance therapy.
    Kawara F; Fujita T; Morita Y; Uda A; Masuda A; Saito M; Ooi M; Ishida T; Kondo Y; Yoshida S; Okuno T; Yano Y; Yoshida M; Kutsumi H; Hayakumo T; Yamashita K; Hirano T; Hirai M; Azuma T
    World J Gastroenterol; 2017 Mar; 23(11):2060-2067. PubMed ID: 28373773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The application of high-resolution endoscopy in non-erosive reflux disease].
    Xue Y; Zhou LY; Lin SR; Huang YH
    Zhonghua Nei Ke Za Zhi; 2006 May; 45(5):389-92. PubMed ID: 16780742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathophysiology and Treatment of PPI-resistant NERD].
    Kawami N; Iwakiri K; Sakamoto C
    Nihon Rinsho; 2015 Jul; 73(7):1197-201. PubMed ID: 26165080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disturbances of the parasympathetic branch of the autonomic nervous system in patients with gastroesophageal reflux disease (GERD) estimated by short-term heart rate variability recordings.
    Dobrek L; Nowakowski M; Mazur M; Herman RM; Thor PJ
    J Physiol Pharmacol; 2004 Jul; 55 Suppl 2():77-90. PubMed ID: 15608363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Esomeprazole for the Treatment of Erosive Esophagitis in Children: An International, Multicenter, Randomized, Parallel-Group, Double-Blind (for Dose) Study.
    Tolia V; Youssef NN; Gilger MA; Traxler B; Illueca M
    J Pediatr Gastroenterol Nutr; 2015 Jul; 60 Suppl 1():S24-30. PubMed ID: 26422095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partial symptom-response to proton pump inhibitors in patients with non-erosive reflux disease or reflux oesophagitis - a post hoc analysis of 5796 patients.
    Bytzer P; van Zanten SV; Mattsson H; Wernersson B
    Aliment Pharmacol Ther; 2012 Oct; 36(7):635-43. PubMed ID: 22860764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demographic, clinical, and psychological characteristics of the heartburn groups classified using the Rome III criteria and factors associated with the responsiveness to proton pump inhibitors in the gastroesophageal reflux disease group.
    Lee KJ; Kwon HC; Cheong JY; Cho SW
    Digestion; 2009; 79(3):131-6. PubMed ID: 19307735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis used to identify factors associated with the effectiveness of proton pump inhibitors against non-erosive reflux disease.
    Hiyama T; Matsuo K; Urabe Y; Fukuhara T; Tanaka S; Yoshihara M; Haruma K; Chayama K
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1326-32. PubMed ID: 19702900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of pre-endoscopy proton pump inhibitor use on the classification of non-erosive reflux disease and erosive oesophagitis.
    Gaddam S; Wani S; Ahmed H; Maddur P; Hall SB; Gupta N; Puli SR; Higbee A; Rastogi A; Bansal A; Sharma P
    Aliment Pharmacol Ther; 2010 Nov; 32(10):1266-74. PubMed ID: 20955446
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erosive esophagitis and nonerosive reflux disease (NERD): comparison of epidemiologic, physiologic, and therapeutic characteristics.
    Fass R
    J Clin Gastroenterol; 2007 Feb; 41(2):131-7. PubMed ID: 17245209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors.
    Yamashita H; Kanamori A; Kano C; Hashimura H; Matsumoto K; Tsujimae M; Yoshizaki T; Momose K; Obata D; Eguchi T; Fujita M; Okada A
    Digestion; 2017; 96(1):52-59. PubMed ID: 28662503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors affecting response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease: a multicenter prospective observational study.
    Matsuhashi N; Kudo M; Yoshida N; Murakami K; Kato M; Sanuki T; Oshio A; Joh T; Higuchi K; Haruma K; Nakada K
    J Gastroenterol; 2015 Dec; 50(12):1173-83. PubMed ID: 25851931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton pump inhibitors in the management of gastroesophageal reflux disease.
    Hrelja N; Zerem E
    Med Arh; 2011; 65(1):52-5. PubMed ID: 21534455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multi-channel electrogastrography and autonomic nervous system function in patients with non-erosive reflux disease and reflux esophagitis].
    Ding ZL; Xu XH; Wang ZF; Ke MY
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):263-5. PubMed ID: 19552845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of Double-Dose Proton Pump Inhibitor-Resistant Non-Erosive Reflux Disease, and Mechanism of Reflux Symptoms and Gastric Acid Secretion-Suppressive Effect in the Presence or Absence of Helicobacter pylori Infection.
    Kawami N; Takenouchi N; Umezawa M; Hoshino S; Hanada Y; Hoshikawa Y; Sano H; Hoshihara Y; Nomura T; Uchida E; Iwakiri K
    Digestion; 2017; 95(2):140-145. PubMed ID: 28161707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.